Sinopharm Group Co. Ltd.
1099
Classifica tra le azioni
#3002
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of... Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Prezzo delle azioni
$1.96
Capitalizzazione di mercato
$6.13B
Variazione (1 giorno)
-0.13%
Variazione (1 anno)
-18.48%
Paese
CN
Scambia Sinopharm Group Co. Ltd. (1099)
Categoria
Healthcare
Numero di azioni in circolazione per Sinopharm Group Co. Ltd. (1099)
Numero di azioni in circolazione al June 2026: 3.12B
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sinopharm Group Co. Ltd., il numero attuale di azioni in circolazione è 3.12B. Alla fine del December 2023, la società aveva 3.12B azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Sinopharm Group Co. Ltd. (1099) dal 2006 al 2026
Azioni in circolazione alla fine di ogni anno
| Anno | Azioni in circolazione | Cambia |
|---|---|---|
| 2026 (TTM) | 3.12B | 0.00% |
| 2024 | 3.12B | 0.00% |
| 2023 | 3.12B | 0.00% |
| 2022 | 3.12B | 0.30% |
| 2021 | 3.11B | 0.00% |
| 2020 | 3.11B | 4.77% |
| 2019 | 2.97B | 0.07% |
| 2018 | 2.97B | 0.08% |
| 2017 | 2.97B | 7.44% |
| 2016 | 2.76B | -0.26% |
| 2015 | 2.77B | 7.04% |
| 2014 | 2.59B | 2.45% |
| 2013 | 2.52B | 5.03% |
| 2012 | 2.40B | 1.97% |
| 2011 | 2.36B | 4.04% |
| 2010 | 2.26B | 25.19% |
| 2009 | 1.81B | 10.50% |
| 2008 | 1.64B | 0.00% |
| 2007 | 1.64B | 0.00% |
| 2006 | 1.64B | 0.00% |
Azioni in circolazione per aziende simili o concorrenti
| Azienda | Azioni in circolazione | Differenza | Il paese |
|---|---|---|---|
| 118.70M | -96.20% |
US
|
|
| - | - |
US
|
|
| 236.00M | -92.44% |
US
|
|
| - | - |
US
|
|
| 11.50B | 268.61% |
AU
|
